PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29111367-0	2017	Synthesis and biological evaluation of novel radioiodinated benzimidazole derivatives for imaging alpha-synuclein aggregates.	benzimidazole	60-73	synuclein alpha	Homo sapiens	98-113	
29111367-3	2017	In order to develop imaging probes targeting alpha-syn aggregates, we synthesized and evaluated three novel radioiodinated benzimidazole (BI) derivatives for selective imaging of alpha-syn aggregates.	benzimidazole	123-136	synuclein alpha	Homo sapiens	179-188	
29111367-3	2017	In order to develop imaging probes targeting alpha-syn aggregates, we synthesized and evaluated three novel radioiodinated benzimidazole (BI) derivatives for selective imaging of alpha-syn aggregates.	benzimidazole	138-140	synuclein alpha	Homo sapiens	45-54	
29111367-3	2017	In order to develop imaging probes targeting alpha-syn aggregates, we synthesized and evaluated three novel radioiodinated benzimidazole (BI) derivatives for selective imaging of alpha-syn aggregates.	benzimidazole	138-140	synuclein alpha	Homo sapiens	179-188	
29111367-4	2017	In binding experiments, BI-2 exhibited the highest selective binding affinity for alpha-syn aggregates among the BI derivatives.	benzimidazole	24-26	synuclein alpha	Homo sapiens	82-91